Literature DB >> 28471894

Diffusion Restriction in the Optic Nerve and Retina in Patients With Carotid Occlusion.

Mikel Vicente1, Alba R Serrano, Neus Falgàs, Sergio Borrego, Sergio Amaro, Carlos Cardenal, Xabier Urra.   

Abstract

OBJECTIVES: The primary role of magnetic resonance imaging (MRI) in a patient with suspected optic neuropathy is to rule out nonischemic disorders, and many of the reported cases of ischemic optic neuropathy with positive neuroimaging are atypical forms of ischemic optic neuropathy. We studied the role of diffusion-weighted images of MRI in patients with ocular ischemia.
METHODS: We describe the clinical, fundoscopic and neuroimaging characteristics of 3 patients with definite ocular ischemia related to occlusion of the carotid artery.
RESULTS: Diffusion-weighted images revealed typical changes of ischemia in a "cup of wine" shape, with increased signal intensity in diffusion-weighted imaging and a decrease in diffusivity in the apparent diffusion coefficient maps. A repeated MRI 8 days after presentation showed persistent hypointensity in apparent diffusion coefficient maps in 1 of the patients.
CONCLUSIONS: Patients with ocular ischemia can disclose typical ischemic changes on dedicated brain MRI sequences. These findings might be beneficial in the diagnosis of patients with acute vision loss.

Entities:  

Mesh:

Year:  2017        PMID: 28471894     DOI: 10.1097/NRL.0000000000000113

Source DB:  PubMed          Journal:  Neurologist        ISSN: 1074-7931            Impact factor:   1.398


  2 in total

1.  Retinal diffusion restrictions in acute branch retinal arteriolar occlusion.

Authors:  Leon Alexander Danyel; M Miszczuk; K Villringer; G Bohner; E Siebert
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

2.  Time Course and Clinical Correlates of Retinal Diffusion Restrictions in Acute Central Retinal Artery Occlusion.

Authors:  L A Danyel; M Miszczuk; F Connolly; K Villringer; G Bohner; M Rossel-Zemkouo; E Siebert
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-15       Impact factor: 4.966

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.